Search
for
Sort by
Research 781–810 of 1000+
- Efficacy of oral afoxolaner (NexGard®) against natural infestations with Heterodoxus spiniger (Phthiraptera: Boopiidae) in dogs under field conditions
- Trichoscopic evaluation in oral tofacitinib and oral betamethasone in the treatment of moderate to severe alopecia areata
- Comparison of Efficacy of Oral Tofacitinib Versus Oral Minoxidil in Patients with Alopecia Areata
- BH06 (P075) A randomized controlled trial comparing the efficacy and safety of oral tofacitinib vs. methotrexate in moderate-to-severe alopecia areata
- Use of low-dose oral minoxidil for hair growth in transgender and gender non-binary adult patients: a retrospective cohort study
- Efficacy and Safety of Oral Betamethasone Mini-Pulses in Moderate to Severe Alopecia Areata
- Recovery Effects of Oral Supplementation with Polar Lipid-Rich Wheat Extracts on Acute Telogen Effluvium: A Randomized Double-Blind Placebo-Controlled Study
- Dose–Response Effects of Oral Melatonin on Reproductive Parameters in Intact Male Pomeranian Dogs With Alopecia X: A Controlled Study
- The Requirement to Monitor Low-dose Oral Minoxidil in the Management of Hair Loss
- Efficacy of Oral Tofacitinib in Alopecia Areata, Alopecia Totalis, and Alopecia Universalis
- Low-dose oral minoxidil for androgenetic alopecia is not associated with blood pressure changes in patients also taking other antihypertensive medications: A multi-center cohort study using TriNetX
- Characterization and Management of Adverse Events of Low-Dose Oral Minoxidil Treatment for Alopecia: A Narrative Review
- ASSESSING THE EFFECTIVENESS AND SAFETY OF LOW-DOSE ORAL MINOXIDIL IN ANDROGENETIC ALOPECIA: A 24-WEEK CLINICAL STUDY
- Efficacy of Oral Supplementation with Serenoa Repens, Pumpkin Seed Extract and Cysteine Combined with Topical Minoxidil 5% Vs Topical Minoxidil 5% Alone in Androgenic Alopecia A Randomised Assessor-Blinded 6-Month, Superiority Trial
- Analysing efficacy of low-dose oral minoxidil, topical minoxidil, and platelet-rich plasma with topical minoxidil combination in patients with androgenetic alopecia: a randomized controlled observer blinded trial
- Spironolactone reduces the risk of low-dose oral minoxidil-induced edema in women with female pattern hair loss.
- TRICHOGRAM OBSERVATION OF ORAL IVERMECTIN THERAPY IN SCABIOSIS AND OTITIS EXTERNA IN DOMESTIC CATS
- Treatment of Androgenetic Alopecia with Low Dose Oral Minoxidil Monotherapy Compared to Combination Therapy with Dutasteride or Finasteride
- Low-dose oral minoxidil for androgenetic alopecia is not associated with significant changes in alcohol consumption: a retrospective study of 21,971 patients
- Low‐dose oral minoxidil in alopecia: evaluating blood pressure changes in patients with abnormal blood pressure—a retrospective study
- Efficacy of oral spironolactone in the treatment of androgenetic alopecia in female patients: A case series of 11 patients
- Expert Consensus Offers Guidance for Treating Hair Loss With Low-Dose Oral Minoxidil
- Gender differences in adverse effects and dosing practices of low-dose oral minoxidil for androgenetic alopecia: a retrospective analysis of 310 patients
- Phototoxic reaction to oral terbinafine due to Tinea capitis in a child.
- Therapeutic potential of oral tofacitinib in alopecia areata: a retrospective study
- Low‐Dose Oral Minoxidil and Associated Adverse Events: Analyses of the FDA Adverse Event Reporting System (FAERS) With a Focus on Pericardial Effusions
- Test With Oral Administration of Clomiphene May Add to Differential Diagnosis of Severe Hyperandrogenism in Postmenopausal Women - A Case Report
- Comparative analysis of low-dose oral minoxidil with spironolactone versus finasteride or dutasteride in female androgenetic alopecia management
- 51297 Low dose oral minoxidil in COVID-19-associated telogen effluvium. A retrospective analysis of 69 patients.
- Assessing low-dose oral minoxidil efficacy in androgenetic alopecia: a comparative study of AGA and AGA unmasked by telogen effluvium